Current Challenges and Future Perspectives of Diagnosis of Hepatitis B Virus
Open Access
- 19 January 2023
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 13 (3) , 368
Abstract
It is estimated that approximately 260 million people worldwide are infected with the hepatitis B virus (HBV), which is one of the leading causes of liver disease and liver cancer throughout the world. Compared with developed countries, low-income and middle-income countries have limited access to resources and advanced technologies that require highly specialized staff for HBV diagnosis. In spite of the heavy burden caused by hepatitis B virus, 90% of people are still undiagnosed. The World Health Organization (WHO) goal of eliminating hepatitis B by 2030 seems very difficult to achieve due to the existing diagnostic infrastructure in low-resource regions. The majority of diagnostic laboratories still use hepatitis B surface antigen (HBsAg)-based tests. WHO’s elimination plan is at risk of derailment due to phases like the window period, immune control, and occult HBV infection (OBI) not being detected by standard tests. Here, in this article, we are focusing on various diagnostic platforms for the better diagnosis of HBV. The aim of the elimination of HBV can only be achieved by detecting all phases of HBV infection, which can be executed by a combined approach of using new marker assays along with advanced pretesting and testing methods.Keywords
This publication has 74 references indexed in Scilit:
- High Endemicity and Low Molecular Diversity of Hepatitis B Virus Infections in Pregnant Women in a Rural District of North CameroonPLOS ONE, 2013
- Occult HBV infectionSeminars in Immunopathology, 2012
- Hepatitis B: Epidemiology and prevention in developing countriesWorld Journal of Hepatology, 2012
- Viral Determinants of Hepatitis B Surface Antigen Seroclearance in Hepatitis B e Antigen–Negative Chronic Hepatitis B PatientsThe Journal of Infectious Diseases, 2011
- HBV genotypes in India: do they influence disease severity?Hepatology Research, 2009
- Hepatitis B virus infection initiates with a large surface protein–dependent binding to heparan sulfate proteoglycansHepatology, 2007
- Cryo‐electron microscopy of hepatitis B virions reveals variability in envelope capsid interactionsThe EMBO Journal, 2007
- Local ablation vs. resection for the treatment of hepatocellular carcinomaHepatology, 2006
- Measurement of hepatitis B virus core‐related antigen is valuable for identifying patients who are at low risk of lamivudine resistanceLiver International, 2005
- Hepatitis B Virus DNA-negative Dane Particles Lack Core Protein but Contain a 22-kDa Precore Protein without C-terminal Arginine-rich DomainJournal of Biological Chemistry, 2005